🚀 Advancing Immunotherapy through Antigen Target Screening
We’re excited to announce the creation of an innovative antigen target library, built from extensive screenings across 1,000+ patients with diverse cancer indications. This well-validated library is one of the most comprehensive in immunotherapy, laying the foundation for selecting optimal targets for precision therapies.
We’re now opening this resource for partnerships and collaborations in areas beyond our internal programs to maximize the impact on patients.
Antigen Target Library
4 December 2024